Related references
Note: Only part of the references are listed.Structure-Function Relationships in the Human P-Glycoprotein (ABCB1): Insights from Molecular Dynamics Simulations
Liadys Mora Lagares et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Recent Advances on P-Glycoprotein (ABCB1) Transporter Modelling with In Silico Methods
Liadys Mora Lagares et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Implication of ABC transporters in non-proliferative diseases
Tatyana A. Grigoreva et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
P-glycoprotein and cancer: what do we currently know?
Carlos Pilotto Heming et al.
HELIYON (2022)
Metabolic and non-metabolic pathways that control cancer resistance to anthracyclines
Tania Capeloa et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
The effects of anthracycline drugs on the conformational distribution of mouse P-glycoprotein explains their transport rate differences
P. H. Nguyen et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Resistance to anti-tubulin agents: From vinca alkaloids to epothilones
Werner Krause
CANCER DRUG RESISTANCE (2019)
Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation
Youngjin Kim et al.
SCIENCE (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
Metabolic carbonyl reduction of anthracyclines - role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents
Kamil Piska et al.
INVESTIGATIONAL NEW DRUGS (2017)
Nilotinib reverses ABCB1/P-glycoprotein-mediated multidrug resistance but increases cardiotoxicity of doxorubicin in a MDR xenograft model
Zhi-yong Zhou et al.
TOXICOLOGY LETTERS (2016)
Molecular Docking Characterizes Substrate-Binding Sites and Efflux Modulation Mechanisms within P-Glycoprotein.
Ricardo J. Ferreira et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Identifying and Characterizing Binding Sites and Assessing Druggability
Thomas A. Halgren
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Stephen G. Aller et al.
SCIENCE (2009)
Role of the multidrug transporter proteins ABCB1 and ABCC2 in the diaplacental transport of talinolol in the term human placenta
Karen May et al.
DRUG METABOLISM AND DISPOSITION (2008)
Novel procedure for modeling ligand/receptor induced fit effects
W Sherman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A population pharmacokinetic model for doxorubicin and doxorubicinol in the presence of a novel MDR modulator, zosuquidar trihydrochloride (LY335979)
S Callies et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)